Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET to Predict Response to Neoadjuvant Pemetrexed and Cisplatin in NSCLC
NCT00227539Phase 2Completed
- Sponsor
- University of Washington
- Start
- Jul 2005
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by University of Washington. Started Jul 2005; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00227539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00227539.